Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

MK-677 Myths Debunked: Side Effects Comparison

The following table contrasts commonly reported myths about MK-677 side effects with evidence-based clinical findings from peer-reviewed literature and Real Peptides' direct experience supplying research-grade ibutamoren to laboratories worldwide. MK-677 cause

This comparison does not assign a generated winner or score.

  • The following table contrasts commonly reported myths about MK-677 side effects with evidence-based clinical findings from peer-reviewed literature and Real Peptides' direct experience supplying research-grade ibutamoren to laboratories worldwide.
  • MK-677 causes permanent HPA axis suppression and chronic cortisol elevation
  • Cortisol increases 15–25% in weeks 1–4, returns to near baseline by week 8 due to receptor downregulation
  • J Clin Endocrinol Metab 1999; 84(8):2705-2711
  • Transient elevation consistent with exercise-induced cortisol response. Not clinically significant for most research models
  • Ibutamoren causes insulin-dependent diabetes
  • Fasting glucose rises 5–15 mg/dL; HbA1c +0.1–0.3%; resolves within 14 days post-discontinuation
  • J Clin Endocrinol Metab 2008; 93(9):3239-3250
  • Functional insulin resistance (GH counter-regulatory). Not pathological. Monitor glucose in metabolically compromised models
  • MK-677 suppresses testosterone and requires PCT
  • Zero statistically significant change in LH, FSH, or testosterone across all published trials
  • J Clin Endocrinol Metab 1998; 83(2):320-325
  • No HPG axis interaction. PCT is scientifically unfounded for MK-677 monotherapy
  • Water retention is a side effect
  • Subcutaneous water retention occurs in 30–50% due to increased aldosterone and ADH signaling from elevated GH/IGF-1
  • Growth Horm IGF Res 2001; 11(3):S105-S112
  • On-target pharmacological effect, not toxicity. Resolves 7–14 days post-cessation. Sodium restriction mitigates severity
  • Long-term use downregulates GH receptors and causes dependency
  • GH pulse amplitude remains elevated through 24 months; no rebound suppression upon discontinuation
  • No tachyphylaxis to GH secretion observed. Endogenous ghrelin signaling resumes normally within 48–72 hours
More references

Related material